PERCEPTIVE ADVISORS LLC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
114
Insider Buys Sum
$817.97M
Insider Sells Quantity
28
Insider Sells Sum
$42.34M

Insider Activity of PERCEPTIVE ADVISORS LLC

According to the SEC Form 4 filings, PERCEPTIVE ADVISORS LLC, being in a position of

  1. director at Immatics N.V.,
    оver the last 12 months, has bought 863060 shares for $7.5M, and sold 0 shares,
    over all time since 2026-08-26, has bought 863060 shares for $7.5M, and sold 0 shares.

Biography of PERCEPTIVE ADVISORS LLC

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $7,499,9911100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-08-26PurchaseImmatics N.V.
IMTX
director
863,060
0.5931%
$8.69$7.5M-11.45%
2025-08-01PurchaseOrchestra BioMed Holdings, Inc.
OBIO
10 percent owner
700,000
1.642%
$2.75$1.93M+63.52%
2025-05-01SaleAcrivon Therapeutics, Inc. Common Stock
ACRV
10 percent owner
298,886
0.9604%
$1.34$400,507+21.05%
2025-04-30SaleAcrivon Therapeutics, Inc. Common Stock
ACRV
10 percent owner
437,881
1.4067%
$1.41$617,412+15%
2025-04-29SaleAcrivon Therapeutics, Inc. Common Stock
ACRV
10 percent owner
250,000
0.7808%
$1.41$352,500+11.11%
2025-04-28SaleAcrivon Therapeutics, Inc. Common Stock
ACRV
10 percent owner
215,283
0.6532%
$1.56$335,841+3.23%
2025-04-25SaleAcrivon Therapeutics, Inc. Common Stock
ACRV
10 percent owner
1.05M
3.9999%
$1.95$2.06M-2.44%
2025-04-03SaleAldeyra Therapeutics, Inc.
ALDX
10 percent owner
3.4M
5.6943%
$1.42$4.83M+249.65%
2025-02-19PurchaseSolid Biosciences Inc.
SLDB
5M
9.5155%
$4.03$20.15M-16.69%
2024-08-12PurchaseMeiraGTx Holdings plc
MGTX
1.25M
1.9341%
$4.00$5M+55.25%
2024-04-11PurchaseAcrivon Therapeutics, Inc. Common Stock
ACRV
10 percent owner
2.35M
8.4743%
$8.50$20M-22.39%
2024-04-05PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
37,712
0.0643%
$4.74$178,755+6.46%
2024-04-04PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
140,281
0.2374%
$4.67$655,112+7.26%
2024-04-03PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
309,847
0.5185%
$4.09$1.27M+20.96%
2024-04-02PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
186,051
0.3061%
$3.44$640,015+41.41%
2024-04-01PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
8,374
0.0141%
$3.25$27,216+53.52%
2024-01-11PurchaseSolid Biosciences Inc.
SLDB
3.41M
12.2033%
$5.53$18.86M+1.75%
2023-12-29PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
115,774
0.2752%
$7.24$838,204-27.94%
2023-12-28PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
126,116
0.2934%
$7.08$892,901-27.57%
2023-12-27PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
79,726
0.1901%
$7.20$574,027-25.87%
Total: 92
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.